| Shannon Morey, | |
|
8657 Villa La Jolla Dr, La Jolla, CA 92037-2356 | |
| (858) 597-0108 | |
| (858) 597-0646 |
| Full Name | Shannon Morey |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 8657 Villa La Jolla Dr, La Jolla, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619369139 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH67503 (California) | Primary |
| 183500000X | Pharmacist | PH234516 (Massachusetts) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Morey, 8657 Villa La Jolla Dr, La Jolla, CA 92037-2356 Ph: () - | Shannon Morey, 8657 Villa La Jolla Dr, La Jolla, CA 92037-2356 Ph: (858) 597-0108 |
News Archive
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that the Company's Inductively Coupled Plasma-Mass Spectrometer (ICP-MS) technology can help insure that traditional Chinese herbal medicines comply with safety guidelines.
In a new Mayo Clinic study, researchers found that more than one-third of chronic cough patients given a CT scan had sinusitis, inflammation of the sinuses. Findings will be presented at the American College of Chest Physicians CHEST 2005 meeting in Montreal.
Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) providing regular approval for Soliris® (eculizumab) for the treatment of adult and pediatric patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA).
Today, Lung Cancer Alliance (LCA) President & CEO Laurie Fenton-Ambrose said the recent breakthrough on CT screening for lung cancer is an extraordinary development in the battle against lung cancer and reiterated her call for an open and balanced public discussion on guidance for those at high risk who may be considering a scan.
At the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO), data were presented from a phase II investigator-sponsored trial paclitaxel poliglumex (Opaxio, CT-2103) in combination with capecitabine in first-line treatment of patients with metastatic breast cancer (MBC).
› Verified 3 days ago
Amy Waller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7544 Girard Ave, La Jolla, CA 92037 Phone: 858-454-0932 Fax: 858-454-8518 | |
Arthur Shen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9350 Campus Point Dr, La Jolla, CA 92037 Phone: 858-657-8512 Fax: 858-657-8621 | |
Pablina Jones, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3855 Health Sciences Dr # 845, La Jolla, CA 92093 Phone: 858-822-6091 Fax: 858-822-6092 | |
Hue Nhan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7525 Eads Ave, La Jolla, CA 92037 Phone: 858-551-8698 | |
Alexander Kent Yee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-249-5682 | |
Paricheh Azimi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-249-6181 | |
Ashley Ta, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-657-7000 |